Summary
Accumulation of platelets in the microvasculature after acute myocardial ischemia may exacerbate tissue injury through the formation of microthrombi and by the release of vasoactive substances. To assess the role of platelets in myocardial ischemic injury and infarction, circulating platelets were reduced by 94±2% (mean±S.E.M.) with sheep antiserum to canine platelets. Regional myocardial ischemia was produced by occlusion of the left circumflex coronary artery (LCCA) for 90 min followed by reperfusion for 5 hours. Infarct size did not differ significantly between antiplatelet serum and nonimmune serum groups: 36±8vs. 43±4% of the area at risk, determined by a post-mortem dual staining technique (p>0.05). A second occlusion-reperfusion control group, sacrificed at 24 hours, did not differ from 5 hr reperfused groups with regard to infarct size. Coronary sinus thromboxane B2 (TXB2) concentrations were not altered significantly by platelet depletion. Histopathologic examination confirmed the presence of necrosis in the infarcted myocardium and revealed substantial leukocytic infiltration in both groups. The results suggest that circulating platelets are not required for the full expression of myocardial ischemic injury resulting from temporary coronary artery occlusion followed by reperfusion.
Similar content being viewed by others
References
Addonizio VP, Wetstein L, Fisher CA, Feldman P, Strauss JF, Harken AH (1982) Mediation of cardiac ischemia by thromboxanes released from human platelets. Surgery 92:292–279
Allan G, Levy R (1981) Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactionsin vitro. J Pharmacol Exp Ther 217:157–161
Bomberger RA, DePalma RG, Ambrose TA, Manalo P (1982) Aspirin and dipyridamole inhibit endothelial healing. Arch Surg 117:1459–1464
Boudoulas H, Karayannacos PE, Lewis RP, Kakos GS, Kilman JW, Vasko JS (1978) Potential effect of lidocaine on ischemic myocardial injury: Experimental and clinical observations. J Surg Res 24:469–476
Burke SE, Antonaccio MJ, Lefer AM (1982) Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial infarction in dogs. Basic Res Cardiol 77:411–422
Coker SJ, Ledingham IM, Parratt JR, Zeitlin IJ (1981) Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs. Br J Pharmacol 72:593–595
El-Maraghi N, Genton E (1980) The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 62:936–944
Factor SM, Cho S, Kirk ES (1982) Nonspecificity of triphenyltetrazolium chloride (TTC) for the gross diagnosis of acute myocardial infarction. Circulation 66:84A
Fitzpatrick FA, Gorman RR, McGuire SC, Kelly RC, Wynalda MA, Sun FF (1977) A radioimmunoassay for thromboxane B2. Analyt. Biochem 82:1–7
Folts JD, Crowell EB, Rowe GG (1976) Platelet aggregation partially obstructed vessels and its elimination with aspirin. Circulation 54:365–370
Goldstein IM, Malmsten CL, Samuelsson B, Weissman G (1977) Prostaglandins, thromboxanes and polymorphonuclear leukocytes. Mediation and modulation of inflammation. Inflammation 2:309–317
Hill JH, Ward PA (1971) The phlogestic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 133:885–900
Hirsh PD, Campbell WB, Willerson JT, Hillis LD (1981) Prostaglandins and ischemic heart disease. Am J Med 71:1009–1026
Hirsh, PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1980) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 302:6–10
Hook B, Kane W, Jolly S, Kunkel S, Abrams G, Lucchesi BR (1983) Effect of neutropenia on myocardial infarct size at 24 hours in the dog. Pharmacologist 25:217A
Hosko MJ, Gross GJ, Warltier DC (1977) Technique for precise graded arterial stenosis and occlusion. Basic Res Cardiol 72:651–659
Huddleston CB, Lupinetti FM, Laws KH, Collins JC, Clanton JA, Hawiger JJ, Oates JA (1983) The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs. Circ Res 52:608–613
Jolly SR, Abrams GD, Romson JL, Bailie MB, Lucchesi BR (1982) Effects of lodoxamide on ischemic reperfused myocardium. J Cardiovasc Pharmacol 4:441–448
Jorgensen L, Rowsell HC, Hovig T, Glynn MF, Mustard JF (1967) Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest 17:616–644
Ksiezycka E, Maroko PR (1983) Reduction by antineutrophil serum of experimental infarct size. Clin Res 31:666A
Laws KH, Clanton JA, Starnes VA, Lupinetti FM, Collins JC, Oates JA, Hammon Jr JW (1983) Kinetics and imaging of Indium-111-labeled autologous platelets in experimental myocardial infarction. Circulation 67:110–116
Lucchesi BR, Burmeister W, Lomas T, Abrams GD (1976) Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC27761). J Pharmacol Exp Ther 199:310–328
McDonald JWD, Ali M, Townsend ER, Cooper JP (1983) Thromboxane synthesis by sources other than platelets in association with complement-induced pulmonary leukostasis and pulmonary hypertension in sheep. Circ Res 52:1–6
Moschos CB, Haider B, DeLaCruz C, Lyons MM, Regan TJ (1978) Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion. Circulation 57:681–684
Moschos CB, Lahir K, Lyons M, Weisse AB, Oldewurtel HA, Regan TJ (1973) Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: Effect of aspirin, dipyridamole and thrombolysis. Am Heart J 86:61–68
Pinckard RN, O'Rourke RA, Crawford MH, Grover FS, McManus LM, Ghidoni JJ, Storrs SB, Olson MS (1980) Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest 66:1050–1056
Rittenhouse-Simmons S, Deykin D (1976) Isolation of membranes from normal and thrombin-treated gel-filtered platelets using a lectin marker. Biochem Biophys Res Comm 426:688–696
Romson JL, Bush LR, Haack D, Lucchesi BR (1980) The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog. J Pharmacol Exp Ther 215:271–278
Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67:1016–1023
Romson JL, Hook BG, Rigot VH, Schork MA, Swanson DP, Lucchesi BR (1982) The effect of ibuprofen on accumulation of Indium-111-labeled platelets and leukocytes in experimental myocardial infarction. Circulation 66:1002–1011
Ruf W, McNamara JJ, Suehiro A, Suehiro G, Wickline SA (1980) Platelet trapping in myocardial infarct in baboons: therapeutic effect of aspirin. Am J Cardiol 46:405–412
Schaper J (1979) Ultrastructure of the myocardium in acute ischemia. In: Schaper W (ed) The pathophysiology of Myocardial Perfusion, p 581, Elsevier-North Holland, New York
Schumacher WA, Buda AJ, Lucchesi BR (1984) Streptokinase thrombolysis in experimental coronary artery thrombosis: Pattern of reflow and effect of a stenosis. Intl J Cardiol, 6:615–627
Smith EF, Lefer AM, Aharony D, Smith JB, Magolda RL, Claremon D, Nicolaou KC (1981) Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog. Prostaglandins 21:443–456
Walker LN, Ramsay MM, Bowyer DE (1983) Endothelial healing following defined injury to rabbit aorta, depth of injury and mode of repair. Atherosclerosis 47: 123–130
Wilkerson RD, Couran PB, Shaikli BS (1983) Severe thrombocytopenia does not limit myocardial infarct size or ventricular arrhythmias after coronary artery occlusion. Fed Proc 42:1360A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jolly, S.R., Schumacher, W.A., Kunkel, S.L. et al. Platelet depletion in experimental myocardial infarction. Basic Res Cardiol 80, 269–279 (1985). https://doi.org/10.1007/BF01907903
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01907903